Menopause is the permanent cessation of menstruation due to the loss of ovarian follicular activity. It is a natural physiological event — a phase in a woman’s life marked by significant hormonal changes that can be associated with several short-term and long-term health effects.
During this time, women may experience various symptoms:
- Vasomotor symptoms: Hot flashes, night sweats
- Psychological symptoms: Irritability, mood swings, anxiety, or sleep disturbances
- Urogenital atrophy: Vaginal dryness, recurrent urinary tract infections, and painful intercourse
- Dermatological symptoms: Dry skin, hair thinning, and brittle nails
However, one of the most serious long-term consequences of menopause is progressive bone loss, known as Postmenopausal Osteoporosis. This condition occurs due to a sharp decline in estrogen levels after menopause, leading to increased bone turnover, accelerated bone loss, and a higher risk of fractures.
Estrogen plays a protective role in bone metabolism by promoting bone formation (via osteoblasts) and reducing bone resorption (via osteoclasts). When estrogen levels drop, bone breakdown exceeds bone formation, resulting in weakened bones. This is a major health problem affecting millions of women worldwide — approximately 1 in 3 postmenopausal women are affected — often called a “silent disease” because it remains unnoticed until a fracture occurs.
Clinical features
- Often asymptomatic until the first fracture
- Back pain due to vertebral compression fractures
- Loss of height and development of kyphosis (stooped posture)
- Fragility fractures of the wrist, hip, or spine
- Associated muscle weakness, imbalance, and increased fall risk
Diagnosis
- Bone Mineral Density (BMD) Evaluation: Using DEXA (Dual-Energy X-ray Absorptiometry) scan
- Laboratory Tests: Serum calcium, phosphate, and vitamin D levels to rule out secondary causes
- Fracture Risk Assessment: Using the FRAX tool to estimate the 10-year risk of major osteoporotic and hip fractures
Risk factors
Modifiable- Low calcium intake
- Smoking
- Excessive alcohol use
- Sedentary lifestyle
- Long-term corticosteroid use
- Low Body Mass Index (BMI)
Non-Modifiable- Family history of osteoporosis or fractures
- Caucasian or Asian ethnicity
- Increasing age
- Early menopause
Management
1. Lifestyle and General Measures- Ensure adequate calcium intake (1,000–2,000 mg/day)
- Vitamin D supplementation (800–1,000 IU/day)
- Regular weight-bearing and muscle-strengthening exercises
- Smoking cessation and moderation of alcohol consumption
- Fall prevention strategies (home safety, vision checks, balance training)
2. Pharmacologic Therapy- Bisphosphonates: First-line therapy for most women
- SERMs (Selective Estrogen Receptor Modulators): Effective in preventing vertebral fractures
- Hormone Replacement Therapy (HRT): May be considered for early postmenopausal women with symptoms, though not first-line due to risks such as thromboembolism and breast cancer
Follow-up and monitoring
- Repeat DEXA scan every 2 years
- Monitor vitamin D and calcium levels
- Ensure adherence to therapy and evaluate for side effects
- Periodic reassessment of fall risk and lifestyle habits
Prevention
- Early identification of at-risk women during the perimenopausal period
- Lifestyle interventions: balanced diet, regular exercise, and smoking/alcohol reduction
- Encourage regular health check-ups, bone density screening, and patient education
Postmenopausal osteoporosis is a major cause of morbidity in aging women — but it is largely preventable. Early detection, patient education, lifestyle modification, and appropriate pharmacologic treatment are the cornerstones of management. A proactive bone health assessment during and after menopause can help prevent the devastating consequences of fragile bones and fractures, ensuring a stronger, healthier future for women everywhere.
Dr. Preeti Prabhakar Shetty, MBBS, MD - Obstetrics & Gynaecology, Senior Consultant Obstetrician,Gynecologist, Apollo Hospitals, Bannerghatta Road, Bangalore